Universal Health Services Inc (UHS)

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Ticker
UHS
Exchange
NYSE
Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$11.07B
52-week range
$140.08 - $246.33

Valuation

Share price
$186.02 (close of Nov 18, 2026)
P/E (TTM)
7.96x
Price to book
1.44x
Price to free cash flow
9.92x
Enterprise value
$17.08B
Book value per share
$133.00

Price performance

PeriodChange
1 day-3.10%
5 days-5.46%
1 month+0.50%
3 months+7.47%
6 months+9.90%
Year to date-14.68%
1 year-18.71%
3 years+36.82%
5 years+47.84%
10 years+51.65%
All time+14,597.87%

Short interest

As of
Oct 30, 2026
Short % of float
6.17%
Shares short
2.55M
Days to cover
3.58
Change since prior report
-3.45%
Source
FINRA consolidated short interest

Members of Congress who disclosed UHS trades

Alan Armstrong · Julia Letlow

Super investors holding UHS

First Eagle Investment (First Eagle Investment Management, LLC) · Richard Pzena (Pzena Investment Management) · Ray Dalio (Bridgewater Associates) · Ken Griffin (Citadel) · Lee Ainslie (Maverick Capital LTD)

Profitability and growth

Return on equity
20.29%
Return on invested capital
12.26%
Return on assets
9.59%
Return on capital employed
16.23%
Net margin
8.57%
EBITDA margin
15.05%
Revenue growth
9.71%
Net income growth
30.36%
Free cash flow growth
-24.40%

Cash flow and balance sheet

Free cash flow yield (TTM)
10.08%
Current ratio
1.37x
Net debt to EBITDA
2.16x

Latest reported year

Period end
Dec 31, 2025
Fiscal year
2025
Revenue
$17.36B
EBITDA
$2.61B
Net income
$1.49B
Earnings per share
$23.42
Interest expense
$156.07M
Shares outstanding
63.58M

Income statement by year

Period endRevenueNet incomeEPS
2025-12-31$17.36B$1.49B$23.42
2024-12-31$15.83B$1.14B$17.16
2023-12-31$14.28B$717.79M$10.35
2022-12-31$13.40B$675.61M$9.23
2021-12-31$12.64B$991.59M$11.99
2020-12-31$11.56B$943.95M$11.06
2019-12-31$11.38B$814.85M$9.16
2018-12-31$10.77B$779.71M$8.35
2017-12-31$10.41B$752.30M$7.86
2016-12-31$9.77B$702.41M$7.22

Margins and returns by year

Period endNet marginReturn on equityReturn on capital
2025-12-318.57%20.29%12.26%
2024-12-317.22%16.92%11.51%
2023-12-315.03%11.58%8.25%
2022-12-315.04%11.33%7.07%
2021-12-317.84%16.01%9.76%
2020-12-318.17%14.74%9.94%
2019-12-317.16%14.61%9.86%
2018-12-317.24%14.27%9.92%
2017-12-317.23%14.89%10.08%
2016-12-317.19%15.28%9.99%

Cash and debt by year

Period endCashDebt
2025-12-31$137.80M$4.00B
2024-12-31$125.98M$4.46B
2023-12-31$119.44M$4.79B
2022-12-31$102.82M$4.73B
2021-12-31$115.30M$4.14B
2020-12-31$1.22B$3.52B
2019-12-31$61.27M$3.90B
2018-12-31$105.22M$3.94B
2017-12-31$74.42M$3.49B
2016-12-31$33.75M$4.03B

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-12-31$849.25M$95.69M
2024-12-31$1.12B$99.35M
2023-12-31$524.74M$87.72M
2022-12-31$262.02M$85.38M
2021-12-31$28.04M$73.69M
2020-12-31$1.63B$65.84M
2019-12-31$804.37M$69.43M
2018-12-31$609.78M$66.58M
2017-12-31$690.08M$56.74M
2016-12-31$813.90M$48.11M

Dividend history

Most recent payment
Sep 1, 2026
Paid in the last twelve months
$0.80
Payment dateDividend per share
2026-09-01$0.20
2026-06-08$0.20
2026-03-02$0.20
2025-12-01$0.20
2025-09-02$0.20
2025-06-02$0.20
2025-03-03$0.20
2024-12-03$0.20

Investor relations

Past earnings dates

ReportedFiscal periodEPS estimate
2026-10-27Sep 2026$5.31
2026-07-27Jun 2026$5.66
2026-04-27Mar 2026$5.29
2026-02-25Dec 2025$5.92
2025-10-27Sep 2025$4.66
2025-07-28Jun 2025$4.85
2025-04-28Mar 2025$4.36
2025-02-26Dec 2024$4.19

Filings and sources

Company website
uhs.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

DaVita Inc. (DVA) · HCA Healthcare, Inc. (HCA) · Abbott Laboratories (ABT) · Medtronic plc (MDT) · Stryker Corp (SYK) · HealthEquity, Inc. (HQY) · Boston Scientific Corp (BSX) · Veeva Systems Inc (VEEV)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades